Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

AI companion aims to boost health Self-Care in older adults

NCT ID NCT07761663

Symptom relief Sponsor: National Yang Ming Chiao Tung University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 12, 2026 · Last updated Aug 13, 2026 · Updated 1 time

Summary

This trial tests whether a smart nursing AI agent can help middle-aged and older adults with mobility limitations improve their health self-management. Participants will be randomly assigned to either use the AI agent for 8 weeks or continue with standard health education. The study will measure changes in sarcopenia risk, nutrition, physical activity, and quality of life to see if the AI agent offers added benefits.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
A smart nursing AI agent that provides daily interaction, reminders, personalized recommendations, activity monitoring, goal setting, motivational support, and health self-management education.
What this could lead to
If effective, this AI agent could offer a new way to support older adults in managing their health at home, potentially improving mobility, nutrition, and quality of life.
What could go wrong
This is a relatively small trial, and the AI agent's benefits may not be confirmed or may not apply to all older adults. There is also a risk that participants may not engage with the technology as expected.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 102 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Aug 2026

An estimate. Start dates often move.

Expected to finish

Aug 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

50 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Patients aged 50 years or older who present with mobility limitations such as gait instability, sarcopenia, joint degeneration, chronic pain, or functional decline 2. Able to ambulate 3. Alert and oriented Exclusion Criteria: 1. Terminal cancer or major illness with a prognosis of left 6 months 2. Moderate to severe dementia or language expression disorders 3. Individuals with significant audiovisual impairments that prevent AI conversation 4. Unable to complete walking tests on their own

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Community-dwelling older adults are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Mobility Limitation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Community-dwelling older adults Middle-aged and older adults Mobility limitations

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • National Yang Ming Chiao Tung University Nursing Building Room 504A Taipei, Nursing Building, No.155, Sec.2, Li-Nong Street,, Taiwan, 112

    Taipei, 112, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.